Ocugenix

Ocugenix is a company headquartered in the United States. Brouky classifies it under Healthcare & Life Sciences.

Ocugenix develops disease-modifying therapies targeting eye diseases such as wet age-related macular degeneration, geographic atrophy, proliferative diabetic retinopathy, and dry eye by activating natural wound healing pathways to resolve inflammation, fibrosis, and pathological vessel growth.